AKT1 and cancer: Here, the data strongly suggest that OSF-2 overexpression acts on cancer cells and/or CAFs extrinsically via stimulation of integrin receptors, rather than by activating proliferation and pro-survival pathways, such as Akt/PKB signaling intrinsically (Figure 9).